1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31955
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCheung, Yee-Ming Melody-
dc.contributor.authorHoermann, Rudolf-
dc.contributor.authorVan, Karen-
dc.contributor.authorWu, Damian-
dc.contributor.authorHealy, Jenny-
dc.contributor.authorChao, Michael-
dc.contributor.authorWhite, Shane-
dc.contributor.authorYeo, Belinda-
dc.contributor.authorZajac, Jeffrey D-
dc.contributor.authorGrossmann, Mathis-
dc.date2022-
dc.date.accessioned2023-01-12T05:33:55Z-
dc.date.available2023-01-12T05:33:55Z-
dc.date.issued2023-02-
dc.identifier.citationClinical endocrinology 2023; 98(2)en_US
dc.identifier.issn1365-2265-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31955-
dc.description.abstractAromatase inhibitor (AI) therapy provides oncological benefits in postmenopausal women with oestrogen receptor-positive breast cancer. However, AI treatment has been associated with increased cardiovascular risk. In nonbreast cancer populations, experimentally induced low oestrogen states and natural transition to menopause have been associated with increases in visceral adipose tissue (VAT), a known surrogate marker for cardiometabolic risk. Given that AI treatment blocks oestradiol production, we hypothesized that AI treatment would increase VAT.en_US
dc.language.isoeng-
dc.subjectaromatase inhibitoren_US
dc.subjectbreast canceren_US
dc.subjectcardiometabolic risken_US
dc.subjectvisceral adipose tissueen_US
dc.subjectvisceral faten_US
dc.titleEffects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical Endocrinologyen_US
dc.identifier.affiliationGeneral Medicineen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen_US
dc.identifier.doi10.1111/cen.14839en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-3875-5698en_US
dc.identifier.orcid0000-0001-8261-3457en_US
dc.identifier.pubmedid36271726-
dc.description.volume98-
dc.description.issue2-
dc.description.startpage190-
dc.description.endpage201-
dc.subject.meshtermssecondaryBreast Neoplasms/drug therapy-
dc.subject.meshtermssecondaryAromatase Inhibitors/therapeutic use-
dc.subject.meshtermssecondaryCardiovascular Diseases/chemically induced-
local.name.researcherChao, Michael
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

74
checked on Jul 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.